Evidence map›Paper›PMID 26603837›Full record

ArticleBlood2016

Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood.

Valerie Tutwiler, Rustem I Litvinov, Andrey P Lozhkin, Alina D Peshkova, Tatiana Lebedeva, Fazoil I Ataullakhanov, Kara L Spiller, Douglas B Cines, John W Weisel

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 1 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 1 synthesis or guideline pooled it, 183 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Protruding Objects in the Membrane Lung Outlet May Increase Thrombogenicity: Fluid Dynamical Insights.ASAIO journal (American Society for Artificial Internal Organs : 1992) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Transcription factor RUNX1 regulates coagulation factor XIII-A (Research and practice in thrombosis and haemostasis · 2025
    Article
  18. Distinct Hemostasis and Blood Composition in Spiny MouseInternational journal of molecular sciences · 2024
    Article
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Valerie TutwilerSchool of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, PA; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
Rustem I LitvinovDepartment of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
Andrey P LozhkinKazan Federal University, Kazan, Russia;
Alina D PeshkovaKazan Federal University, Kazan, Russia;
Tatiana LebedevaDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; and.
Fazoil I AtaullakhanovHemaCore Ltd., Moscow, Russia.
Kara L SpillerSchool of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, PA;
Douglas B CinesDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; and.
John W WeiselDepartment of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
University of Pennsylvania · USDrexel University · USKazan Federal University · RU

Funding

TRAINING GRANT IN HEMOSTASIS AND THROMBOSIST32HL007971 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Rodney M Camire · 2001 to 2026
$10.6M
Structural origin of fibrin clot mechanical propertiesR01HL090774 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI WEISEL, JOHN W · 2009 to 2012
$1.6M
Structural origin of fibrin clot mechanical propertiesR56HL090774 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI WEISEL, JOHN W · 2014 to 2014
$408k
NHLBI NIH HHS HL090774NHLBI NIH HHS R01 HL090774NHLBI NIH HHS R56 HL090774NHLBI NIH HHS T32 HL007971PHS HHS T32 H10791
6 · The paper itself

Abstract

Platelet-driven blood clot contraction (retraction) is thought to promote wound closure and secure hemostasis while preventing vascular occlusion. Notwithstanding its importance, clot contraction remains a poorly understood process, partially because of the lack of methodology to quantify its dynamics and requirements. We used a novel automated optical analyzer to continuously track in vitro changes in the size of contracting clots in whole blood and in variously reconstituted samples. Kinetics of contraction was complemented with dynamic rheometry to characterize the viscoelasticity of contracting clots. This combined approach enabled investigation of the coordinated mechanistic impact of platelets, including nonmuscle myosin II, red blood cells (RBCs), fibrin(ogen), factor XIIIa (FXIIIa), and thrombin on the kinetics and mechanics of the contraction process. Clot contraction is composed of 3 sequential phases, each characterized by a distinct rate constant. Thrombin, Ca(2+), the integrin αIIbβ3, myosin IIa, FXIIIa cross-linking, and platelet count all promote 1 or more phases of the clot contraction process. In contrast, RBCs impair contraction and reduce elasticity, while increasing the overall contractile stress generated by the platelet-fibrin meshwork. A better understanding of the mechanisms by which blood cells, fibrin(ogen), and platelet-fibrin interactions modulate clot contraction may generate novel approaches to reveal and to manage thrombosis and hemostatic disorders.

Indexed as

Blood CoagulationBlood PlateletsCalciumClot RetractionCross-Linking ReagentsErythrocytesFactor XIIIaFibrinHemostasisHumansKineticsNonmuscle Myosin Type IIAPlatelet Glycoprotein GPIIb-IIIa ComplexRheologyThrombinThrombosisCalciumCross-Linking ReagentsFactor XIIIaFibrinNonmuscle Myosin Type IIAPlatelet Glycoprotein GPIIb-IIIa ComplexThrombin

Identifiers

PMID26603837
PMCPMC4705605
OpenAlexW2257788424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.